Knowledge

BioBrick

Source 📝

20: 141:
a part to the community sign the Contributor Agreement, agreeing not to assert against Users Contributor-held intellectual property rights that might limit the use of the contributed materials. Signers of the User Agreement may freely use the whole collection of parts given by contributors. There is no requirement for users to contribute to the community in order to use the parts, and users may assert intellectual property rights to inventions developed by using the parts. The User Agreement allows users to establish invention of uses of parts, to disclose patents on parts combinations, and to freely build on the contributions of other users.
413:
resistance genes. This method reduces noise from uncut plasmids by amplifying a desired insert using PCR prior to digestion and treating the mixture with the restriction enzyme DpnI, which digests methylated DNA like plasmids. Eliminating the template plasmids with DpnI leaves only the insert to be amplified by PCR. To decrease the possibility of creating plasmids with unwanted combinations of insert and backbone, the backbone can be treated with phosphatase to prevent its religation.
73: 170: 404:
a correctly assembled plasmid. The destination plasmids also have different antibiotic resistance genes than the plasmids carrying the BioBrick parts. All three plasmids are digested with an appropriate restriction enzyme and then allowed to ligate. Only the correctly assembled part will produce a viable composite part contained in the destination plasmid. This allows a good selection as only the correctly assembled BioBrick parts survive.
464:
components. One example of a professional parts registry is the USA-based publicly funded facility, The International Open Facility Advancing Biotechnology (BIOFAB), which contains detailed descriptions of each biological part. It is also an open-source registry, and is available commercially. BIOFAB aims to catalogue high-quality BioBrick parts to accommodate the needs of professional synthetic biology community.
323: 132:. BioBricks Foundation's activities include hosting SBx.0 Conferences, technical and educational programs. The SBx.0 conferences are international conferences on synthetic biology hosted across the world. Technical programs are aimed at the production of a series of standard biological parts, and their education expansion is creating acts which help create open, standardized sources of biological parts. 111:. This team introduced a cloning strategy for the assembly of short DNA fragments. However, this early attempt was not widely recognised by the scientific research community at the time. In 1999, Arkin and Endy realized that the heterogeneous elements that made up a genetic circuit were lacking standards, so they proposed a list of standard biological parts. BioBricks were described and introduced by 459:
Every BioBrick part has its unique identification code which makes the search for the desired BioBrick part easier (for example, BBa_J23100, a constitutive promoter). The registry is open access, whereby anyone can submit a BioBrick part. Most of the BioBrick submission is from students participating
403:
The 3A assembly method is the most commonly used, as its compatible with assembly Standard 10, Silver standard as well as the Freiburg standard. This assembly method involves two BioBrick parts and a destination plasmid. The destination plasmid contains a toxic (lethal) gene, to ease the selection of
282:
Tom Knight later developed the BB-2 assembly standard in 2008 to address problems with joining the scars of protein domains and that the scars consist of eight bases, which will yield an altered reading frame when joining protein domains. The enzymes used for digestion of the initial parts are almost
140:
As an alternative to traditional biotechnology patent systems and in an effort to allow BioBricks to be utilized as an open-source community standard, the BioBricks Foundation created the BioBrick Public Agreement, which consists of a Contributor Agreement and a User Agreement. Those who want to give
438:
The 4R/2M assembly method was designed to combine parts (BioBrick Assembly Standard 10 or Silver Standard) within existing plasmids (i.e. without PCR or subcloning). The plasmids are reacted in vivo with sequence-specific DNA methyltransferases, so that each is modified and protected from one of two
467:
The BioBrick Foundation (BBF) is a public-benefit organization established to promote the use of standardized BioBrick parts on a scale beyond the iGEM competition. The BBF is currently working on the derivation of standard framework to promote the production high quality BioBrick parts which would
447:
The MIT group led by Tom Knight that developed BioBricks and International Genetically Engineered Machines (iGEM) competition are also the pioneers of The Registry of Standard Biological Parts (Registry). Registry being one of the foundations of synthetic biology, provides web-based information and
338:
Pam Silver's lab created the Silver assembly standard to overcome the issue surrounding the formation of fusion protein. This assembly standard is also known as Biofusion standard, and is an improvement of the BioBrick assembly standard 10. Silver's standard involves deletion of one nucleotide from
463:
Professional parts registries have also been developed. Since most of the BioBrick parts are submitted by undergraduates as part of the iGEM competition, the parts may lack important characterisation data and metadata which would be essential when it comes to designing and modelling the functional
308:
GATCCaaaCTCGAG), and lacking in these same restriction sites internally. The upstream part in the pairwise assembly is purified from an EcoRI/BamHI digest, and the downstream part+vector is purified from an EcoRI/BglII digest. Ligation of these two fragments creates a composite part reforming the
291:
The BglBrick assembly standard was proposed by J. Christopher Anderson, John E. Dueber, Mariana Leguia, Gabriel C. Wu, Jonathan C. Goler, Adam P. Arkin, and Jay D. Keasling in September 2009 as a standard very similar in concept to BioBrick, but enabling the generation of fusion proteins without
412:
The amplified insert assembly method does not depend on prefix and suffix sequences, allowing to be used in combination with a majority of assembly standards. It also has a higher transformation rate than 3A assembly, and it does not require the involved plasmids to have different antibiotic
270:
process: multiple applications do not change the end product, and maintain the prefix and suffix. Although the BioBrick standard assembly allows for the formation of functional modules, there is a limitation to this standard 10 approach. The 8 bp scar site does not allow the creation of a
153:
methods. The BioBrick assembly standard is a more reliable approach for combining parts to form larger composites. The assembly standard enables two groups of synthetic biologists in different parts of the world to re-use a BioBrick part without going through the whole cycle of design and
160:
cloning method, the assembly standard process is faster and promotes automation. The BioBrick assembly standard 10 was the first assembly standard to be introduced. Over the years, several other assembly standards, such as the Biofusion standard and Freiburg standard have been developed.
394:
Different methods are used when it comes to assembling BioBricks. This is because some standards require different materials and methods (use of different restriction enzymes), while others are due to preferences in protocol because some methods of assembly have higher efficiency and is
385:
respectively. This scar sequence results in a much more stable protein as the glycine forms a stable N-terminal, unlike the arginine, which signals for N-terminal degradation. The assembly technique proposed by the Freiburg team diminishes the limitations of the Biofusion standard.
127:
The BioBricks Foundation was formed in 2006 by engineers and scientists alike as a not-for-profit organization to standardize biological parts across the field. The Foundation focuses on improving in areas of Technology, Law, Education and the Global Community as they apply to
217:(P) sites. The prefix and the suffix are not considered part of the BioBrick part. To facilitate the assembly process, the BioBrick part itself must not contain any of these restriction sites. During the assembly of two different parts, one of the plasmids is digested with 371:
The 2007 Freiburg iGEM team introduced a new assembly standard to overcome the disadvantages of the existing Biofusion standard technique. The Freiburg team created a new set of prefix and suffix sequences by introducing additional restriction enzyme sites,
429:
ends of sequences, creating single-stranded DNA in the ends of all sequences where the different components are designed to anneal. DNA polymerase then adds DNA parts to gaps in the anneal components, and a Taq ligase can seal the final strands.
98:
The development of standardized biological parts allows for the rapid assembly of sequences. The ability to test individual parts and devices to be independently tested and characterized also improves the reliability of higher-order systems.
380:
to the existing prefix and suffix respectively. These newly introduced restriction enzyme sites are BioBrick standard compatible. The Freiburg standard still forms a 6 bp scar site, but the scar sequence (ACCGGC) now codes for threonine and
253:
sites will also ligate as the digestion produces compatible ends. Now, both the DNA parts are in one plasmid. The ligation produces an 8 base pair "scar" site between the two BioBrick parts. Since the scar site is a hybrid of the
313:
scar sequence at the junction of the parts, a scar that encodes the amino acids glycine and serine when fusing CDS parts together in-frame, convenient due to the GlySer dipeptide being a popular linker of protein domains.
262:
sites, it is not recognized by either restriction enzyme. The prefix and suffix sequences remain unchanged by this digestion and ligation process, which allows for subsequent assembly steps with more BioBrick parts.
189:. The vector acts as a transport system to carry the BioBrick parts. The first approach towards a BioBrick standard was the introduction of standard sequences, the prefix and suffix sequences, which flank the 5 460:
in the annual iGEM competition hosted every summer. The Registry allows exchange of data and materials online which allows rapid re-use and modifications of parts by the participating community.
347:
site, which shortens the scar site by 2 nucleotides, which now forms a 6 bp scar sequence. The 6 bp sequence allows the reading frame to be maintained. The scar sequence codes for the amino acid
292:
altering the reading frame or introducing stop codons and while creating a relatively neutral amino acid linker scar (GlySer). A BglBrick part is as a DNA sequence flanked by 5
421:
The Gibson scarless assembly method allows the joining of multiple BioBricks simultaneously. This method requires the desired sequences to have an overlap of 20 to 150
80:
The BioBrick parts are used by applying engineering principles of abstraction and modularization. BioBrick parts form the base of the hierarchical system on which
623: 425:. Because BioBricks do not have this overlap, this method requires PCR primers to create overhangs between adjacent BioBricks. T5 exonuclease attacks the 5 326:
Biofusion assembly of two BioBrick parts.The schematic diagram shows the 6 base pair scar site made due to the deletion and insertion of nucleotide in the
154:
manipulation. This means the newly designed part can be used by other teams of researchers more easily. Besides that, when compared to the old-fashioned
821:
Mark, Fischer; Lee, Crews; Jennifer, Lynch; Jason, Schultz; David, Grewal; Drew, Endy (2009-10-18). "The BioBrick Public Agreement v1 (draft)".
1094: 487: 91:
Device: Collection set of parts with defined function. In simple terms, a set of complementary BioBrick parts put together forms a device.
119:
in 2003. Since then, various research groups have utilized the BioBrick standard parts to engineer novel biological devices and systems.
359:
is a disadvantage to the Biofusion assembly technique: these properties of arginine result in the destabilisation of the protein by the
42:
from individual parts and combinations of parts with defined functions, which would then be incorporated into living cells such as
197:
ends of the DNA part respectively. These standard sequences encode specific restriction enzyme sites. The prefix sequence encodes
355:(AGA). This minor improvement allows for the formation of in-frame fusion protein. However, arginine's being a large, charged 173:
Standard assembly of two BioBrick parts (promoter and coding sequence) by digestion and ligation which forms a "scar" site(M).
1048: 1073: 177:
Assembly standard 10 was developed by Tom Knight, and is the most widely used assembly standard. It involves the use of
1165: 719: 1002: 630: 1205: 743: 1113: 19: 39: 772: 1237: 149:
The BioBrick assembly standard was introduced to overcome the lack of standardization posed by traditional
279:
which prevents the continuous reading of codons, which is required for the formation of fusion protein.
1242: 186: 1140:
Matsumura I. 2020. Methylase-assisted subcloning for high throughput BioBrick assembly. PeerJ 8:e9841
1031:
Røkke, G.; Korvald, E.; Pahr, J.; Oyås, O.; Lale, R. (2014-01-01). Valla, Svein; Lale, Rahmi (eds.).
847: 439:
restriction endonucleases that are later used to linearize undesired circular ligation products.
1098: 112: 53: 861:
Smolke, Christina D (2009). "Building outside of the box: iGEM and the BioBricks Foundation".
23:
Synthetic Biology Open Language (SBOL) standard visual symbols for use with BioBricks Standard
834: 61: 672: 8: 178: 49: 676: 986: 951: 926: 886: 597: 562: 35: 455:
Includes a catalogue which describes the function, performance and design of each part
1161: 1054: 1044: 1008: 998: 956: 878: 700: 695: 656: 602: 584: 482: 477: 150: 129: 81: 1036: 990: 982: 946: 938: 890: 870: 822: 690: 680: 592: 574: 532: 44: 88:
Parts: Pieces of DNA that form a functional unit (for example promoter, RBS, etc.)
57: 1040: 924: 107:
The first attempt to create a list of standard biological parts was in 1996, by
38:
assembly standard. These building blocks are used to design and assemble larger
925:
Sleight, S. C.; Bartley, B. A.; Lieviant, J. A.; Sauro, H. M. (12 April 2010).
272: 979:
Assembly of BioBrick standard biological parts using three antibiotic assembly
48:
cells to construct new biological systems. Examples of BioBrick parts include
1231: 1035:. Methods in Molecular Biology. Vol. 1116. Humana Press. pp. 1–24. 904: 685: 588: 528: 1058: 1012: 960: 882: 606: 1114:"dspace.mit.edu/bitstream/handle/1721.1/45140/BBF_RFC%2025.pdf?sequence=1" 1074:"A New Biobrick Assembly Strategy Designed for Facile Protein Engineering" 704: 579: 1209: 942: 874: 751: 276: 1033:
BioBrick Assembly Standards and Techniques and Associated Software Tools
994: 826: 536: 72: 360: 356: 267: 169: 94:
System: Combination of a set of devices that performs high-level tasks.
452:
Information and characterisation data for all parts, device and system
309:
original flanking sites required in the part definition and leaving a
1141: 422: 348: 322: 654: 233:. This leaves both plasmids with 4 base pair (bp) overhangs at the 5 655:
Rebatchouk, Dmitri; Daraselia, N.; Narita, J. O. (1 October 1996).
504: 352: 245:
sites will ligate since they are complementary to each other. The
801: 780: 382: 182: 661:
DNA manipulation applied to promoter analysis and vector design"
225:. The plasmid carrying the other BioBrick part is digested with 156: 977:
Shetty, R.; Lizarazo, M.; Rettberg, R.; Knight, T. F. (2011).
561:
Knight, Thomas F; Reshma P Shetty; Drew Endy (14 April 2008).
560: 181:. Every BioBrick part is a DNA sequence which is carried by a 529:"Idempotent Vector Design for Standard Assembly of Biobricks" 199: 1181: 976: 448:
data on over 20,000 BioBrick parts. The Registry contains:
213: 981:. Methods in Enzymology. Vol. 498. pp. 311–26. 116: 76:
Abstraction hierarchy allows the breakdown of complexity.
31: 499: 433: 1072:
Silver, Pamela A.; Ira E. Phillips (April 18, 2006).
1071: 897: 1030: 820: 802:"Frequently Asked Questions | BioBricks Foundation" 283:the same, but with modified prefixes and suffixes. 84:is based. There are three levels to the hierarchy: 920: 918: 618: 616: 563:"Engineering BioBrick vectors from BioBrick parts" 1105: 1229: 1095:"Freiburg07/report fusion parts - 2007.igem.org" 927:"In-Fusion BioBrick assembly and re-engineering" 720:"A Standard Parts List for Biological Circuitry" 164: 915: 665:Proceedings of the National Academy of Sciences 613: 317: 286: 972: 970: 398: 207:(X) sites, while the suffix sequence encodes 144: 135: 16:Standard for components used in DNA synthesis 407: 1151: 1149: 416: 967: 950: 694: 684: 648: 596: 578: 1146: 556: 554: 552: 550: 548: 546: 522: 520: 321: 168: 71: 18: 1155: 122: 1230: 860: 526: 1026: 1024: 1022: 543: 517: 505:Registry of Standard Biological Parts 711: 366: 1198: 434:Methylase-assisted (4R/2M) Assembly 13: 1142:https://doi.org/10.7717/peerj.9841 1111: 1019: 987:10.1016/B978-0-12-385120-8.00013-9 389: 14: 1254: 1097:. August 29, 2021. Archived from 773:"Programs - BioBricks Foundation" 717: 657:"NOMAD: a versatile strategy for 567:Journal of Biological Engineering 493: 468:be freely available to everyone. 442: 296:EcoRI and BglII sites (GAATTCaaaA 1174: 1160:. London: Imperial College Pr. 1134: 1087: 1065: 854: 814: 794: 765: 744:"About - BioBricks Foundation" 736: 1: 510: 165:BioBrick assembly standard 10 54:ribosomal binding sites (RBS) 40:synthetic biological circuits 34:sequences which conform to a 1206:"About BioBricks Foundation" 624:"SynBio Standards -BioBrick" 7: 1041:10.1007/978-1-62703-764-8_1 471: 318:Silver (Biofusion) standard 287:BglBricks assembly standard 67: 10: 1259: 1182:"Main Page - ung.igem.org" 1158:Synthetic Biology A Primer 399:3 Antibiotic (3A) Assembly 145:BioBrick Assembly standard 136:BioBricks Public Agreement 102: 408:Amplified Insert Assembly 275:. The scar site causes a 686:10.1073/pnas.93.20.10891 417:Gibson Scarless Assembly 1156:Baldwin, Geoff (2012). 905:"The BioBrick approach" 527:Knight, Thomas (2003). 1081:Harvard Medical School 931:Nucleic Acids Research 842:Cite journal requires 335: 304:BamHI and XhoI sites ( 174: 77: 24: 580:10.1186/1754-1611-2-5 325: 172: 75: 22: 1112:Muller, Kristian M. 875:10.1038/nbt1209-1099 863:Nature Biotechnology 777:BioBricks Foundation 748:BioBricks Foundation 500:BioBricks Foundation 266:This assembly is an 123:BioBricks Foundation 1238:Genetics techniques 1212:on 13 November 2015 677:1996PNAS...9310891R 671:(20): 10891–10896. 179:restriction enzymes 943:10.1093/nar/gkq179 336: 185:, which acts as a 175: 78: 36:restriction-enzyme 25: 1243:Synthetic biology 1050:978-1-62703-763-1 869:(12): 1099–1102. 478:Synthetic biology 367:Freiburg standard 151:molecular cloning 130:synthetic biology 82:synthetic biology 1250: 1222: 1221: 1219: 1217: 1208:. Archived from 1202: 1196: 1195: 1193: 1192: 1178: 1172: 1171: 1153: 1144: 1138: 1132: 1131: 1129: 1127: 1118: 1109: 1103: 1102: 1091: 1085: 1084: 1078: 1069: 1063: 1062: 1028: 1017: 1016: 974: 965: 964: 954: 937:(8): 2624–2636. 922: 913: 912: 901: 895: 894: 858: 852: 851: 845: 840: 838: 830: 818: 812: 811: 809: 808: 798: 792: 791: 789: 788: 779:. Archived from 769: 763: 762: 760: 759: 750:. Archived from 740: 734: 733: 731: 729: 724: 715: 709: 708: 698: 688: 652: 646: 645: 643: 641: 636:on 27 March 2014 635: 629:. Archived from 628: 620: 611: 610: 600: 582: 558: 541: 540: 524: 488:iGEM Competition 428: 303: 295: 240: 236: 196: 192: 183:circular plasmid 109:Rebatchouk et al 58:coding sequences 45:Escherichia coli 1258: 1257: 1253: 1252: 1251: 1249: 1248: 1247: 1228: 1227: 1226: 1225: 1215: 1213: 1204: 1203: 1199: 1190: 1188: 1180: 1179: 1175: 1168: 1154: 1147: 1139: 1135: 1125: 1123: 1116: 1110: 1106: 1093: 1092: 1088: 1076: 1070: 1066: 1051: 1029: 1020: 1005: 975: 968: 923: 916: 903: 902: 898: 859: 855: 843: 841: 832: 831: 819: 815: 806: 804: 800: 799: 795: 786: 784: 771: 770: 766: 757: 755: 742: 741: 737: 727: 725: 722: 716: 712: 653: 649: 639: 637: 633: 626: 622: 621: 614: 559: 544: 525: 518: 513: 496: 474: 445: 436: 426: 419: 410: 401: 395:user-friendly. 392: 390:Assembly method 369: 320: 301: 293: 289: 238: 234: 194: 190: 167: 147: 138: 125: 105: 70: 17: 12: 11: 5: 1256: 1246: 1245: 1240: 1224: 1223: 1197: 1173: 1167:978-1848168633 1166: 1145: 1133: 1104: 1101:on 2021-08-29. 1086: 1064: 1049: 1018: 1003: 966: 914: 896: 853: 844:|journal= 813: 793: 764: 735: 710: 647: 612: 542: 515: 514: 512: 509: 508: 507: 502: 495: 494:External links 492: 491: 490: 485: 480: 473: 470: 457: 456: 453: 444: 443:Parts Registry 441: 435: 432: 418: 415: 409: 406: 400: 397: 391: 388: 368: 365: 319: 316: 288: 285: 273:fusion protein 166: 163: 146: 143: 137: 134: 124: 121: 104: 101: 96: 95: 92: 89: 69: 66: 15: 9: 6: 4: 3: 2: 1255: 1244: 1241: 1239: 1236: 1235: 1233: 1211: 1207: 1201: 1187: 1183: 1177: 1169: 1163: 1159: 1152: 1150: 1143: 1137: 1122: 1115: 1108: 1100: 1096: 1090: 1082: 1075: 1068: 1060: 1056: 1052: 1046: 1042: 1038: 1034: 1027: 1025: 1023: 1014: 1010: 1006: 1004:9780123851208 1000: 996: 992: 988: 984: 980: 973: 971: 962: 958: 953: 948: 944: 940: 936: 932: 928: 921: 919: 910: 906: 900: 892: 888: 884: 880: 876: 872: 868: 864: 857: 849: 836: 828: 824: 817: 803: 797: 783:on 2015-09-17 782: 778: 774: 768: 754:on 2015-11-13 753: 749: 745: 739: 721: 718:Arkin, Adam. 714: 706: 702: 697: 692: 687: 682: 678: 674: 670: 666: 662: 660: 651: 632: 625: 619: 617: 608: 604: 599: 594: 590: 586: 581: 576: 572: 568: 564: 557: 555: 553: 551: 549: 547: 538: 534: 530: 523: 521: 516: 506: 503: 501: 498: 497: 489: 486: 484: 481: 479: 476: 475: 469: 465: 461: 454: 451: 450: 449: 440: 431: 424: 414: 405: 396: 387: 384: 379: 375: 364: 362: 358: 354: 350: 346: 342: 333: 329: 324: 315: 312: 307: 299: 284: 280: 278: 274: 269: 264: 261: 257: 252: 248: 244: 232: 228: 224: 220: 216: 215: 210: 206: 202: 201: 188: 184: 180: 171: 162: 159: 158: 152: 142: 133: 131: 120: 118: 114: 110: 100: 93: 90: 87: 86: 85: 83: 74: 65: 63: 59: 55: 51: 47: 46: 41: 37: 33: 29: 21: 1214:. Retrieved 1210:the original 1200: 1189:. Retrieved 1185: 1176: 1157: 1136: 1124:. Retrieved 1120: 1107: 1099:the original 1089: 1080: 1067: 1032: 995:1721.1/65066 978: 934: 930: 908: 899: 866: 862: 856: 835:cite journal 827:1721.1/49434 816: 805:. Retrieved 796: 785:. Retrieved 781:the original 776: 767: 756:. Retrieved 752:the original 747: 738: 726:. Retrieved 713: 668: 664: 658: 650: 638:. Retrieved 631:the original 570: 566: 537:1721.1/21168 466: 462: 458: 446: 437: 420: 411: 402: 393: 377: 373: 370: 344: 340: 337: 331: 327: 310: 305: 297: 290: 281: 265: 259: 255: 250: 246: 242: 230: 226: 222: 218: 212: 208: 204: 198: 176: 155: 148: 139: 126: 108: 106: 97: 79: 43: 27: 26: 909:j5.jbei.org 277:frame shift 62:terminators 1232:Categories 1191:2015-11-10 807:2021-10-19 787:2015-11-04 758:2015-11-04 511:References 361:N-end rule 357:amino acid 351:(ACT) and 268:idempotent 241:ends. The 113:Tom Knight 30:parts are 589:1754-1611 349:threonine 50:promoters 1216:27 March 1186:igem.org 1126:27 March 1059:24395353 1013:21601683 961:20385581 883:20010584 728:27 March 659:in vitro 640:27 March 607:18410688 573:(5): 5. 472:See also 353:arginine 211:(S) and 203:(E) and 68:Overview 28:BioBrick 952:2860134 891:5486814 705:8855278 673:Bibcode 598:2373286 483:Wetware 383:glycine 300:) and 3 103:History 1164:  1083:: 1–6. 1057:  1047:  1011:  1001:  959:  949:  889:  881:  703:  693:  605:  595:  587:  378:NgoMIV 334:sites. 311:GGATCT 187:vector 157:ad hoc 1117:(PDF) 1077:(PDF) 887:S2CID 723:(PDF) 696:38253 634:(PDF) 627:(PDF) 298:GATCT 243:EcoRI 237:and 3 227:EcoRI 219:EcoRI 200:EcoRI 193:and 3 1218:2014 1162:ISBN 1128:2014 1055:PMID 1045:ISBN 1009:PMID 999:ISBN 957:PMID 879:PMID 848:help 730:2014 701:PMID 642:2014 603:PMID 585:ISSN 376:and 374:AgeI 345:SpeI 343:and 341:Xbal 339:the 332:SpeI 330:and 328:XbaI 260:SpeI 258:and 256:Xbal 251:SpeI 249:and 247:Xbal 231:Xbal 229:and 223:SpeI 221:and 214:PstI 209:SpeI 205:Xbal 60:and 1121:MIT 1037:doi 991:hdl 983:doi 947:PMC 939:doi 871:doi 823:hdl 691:PMC 681:doi 593:PMC 575:doi 533:hdl 423:bps 117:MIT 115:at 32:DNA 1234:: 1184:. 1148:^ 1119:. 1079:. 1053:. 1043:. 1021:^ 1007:. 997:. 989:. 969:^ 955:. 945:. 935:38 933:. 929:. 917:^ 907:. 885:. 877:. 867:27 865:. 839:: 837:}} 833:{{ 775:. 746:. 699:. 689:. 679:. 669:93 667:. 663:. 615:^ 601:. 591:. 583:. 569:. 565:. 545:^ 531:. 519:^ 363:. 64:. 56:, 52:, 1220:. 1194:. 1170:. 1130:. 1061:. 1039:: 1015:. 993:: 985:: 963:. 941:: 911:. 893:. 873:: 850:) 846:( 829:. 825:: 810:. 790:. 761:. 732:. 707:. 683:: 675:: 644:. 609:. 577:: 571:2 539:. 535:: 427:′ 306:G 302:′ 294:′ 239:′ 235:′ 195:′ 191:′

Index


DNA
restriction-enzyme
synthetic biological circuits
Escherichia coli
promoters
ribosomal binding sites (RBS)
coding sequences
terminators

synthetic biology
Tom Knight
MIT
synthetic biology
molecular cloning
ad hoc

restriction enzymes
circular plasmid
vector
EcoRI
PstI
idempotent
fusion protein
frame shift

threonine
arginine
amino acid
N-end rule

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.